Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | CRVS Corvus Pharmaceuticals, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $11.62 -1.5% | $14.86 -2.5% |
| StockIQ Score | 46D+ Moderate Risk: Medium | 36F Weak Risk: Medium |
| Technical | 16F | 13F |
| Fundamental | 50C- | 35F |
| Growth | 66B- | 50C- |
| Fair Value | 38F | 38F |
| News | 80A- | 50C- |
| Quality | 55C | 50C- |
| Risk | 54C- | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Corvus Pharmaceuticals (CRVS) outperforms Ascentage Pharma (AAPG) in nearly every category. CRVS has a stronger investor score (52 vs. 37), a higher growth score (66 vs. 50), and a more favorable moderate rating compared to AAPG’s weak rating. The only tie is in valuation (both at 38), but CRVS leads in technical (48 vs. 18) and fundamental (46 vs. 35) scores.
